ViewRay (VRAY) Announces Proposed $75M Public Offering of Common Stock

Go back to ViewRay (VRAY) Announces Proposed $75M Public Offering of Common Stock

ViewRay Announces Proposed Public Offering of Common Stock

December 2, 2019 4:02 PM EST

CLEVELAND, Dec. 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten public offering of $75.0 million of shares of its common stock.  In addition, ViewRay expects to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of shares of common stock at the public offering price, less the underwriting discounts and commissions.  All of the shares of common stock to be sold in the... More

ViewRay Announces Collaborations with Elekta and Medtronic

December 2, 2019 4:01 PM EST

CLEVELAND, Dec. 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that it has signed a non-binding memorandum of understanding for collaboration with Elekta AB (Nasdaq: EKTA-B.ST) ("Elekta") to advance the knowledge and use of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay, subject to the terms and conditions set forth in a commitment agreement.

Additionally, ViewRay has signed a non-binding memorandum of understanding with Medtronic (NYSE: MDT) to... More